It is our honor and pleasure to invite you to participate in the 19th MIXiii-BIOMED Conference and Exhibition, to be held May 12-14, 2020 in Tel Aviv, Israel.
Within the arena of health care, quality of life is viewed as multidimensional, encompassing emotional, physical, material, and social well-being. Human lifespan could soon pass 100 years thanks to medical science and technology. Artificial intelligence, machine learning, genomics and other technologies may lead to an extended life. In today’s modern society, there exists a “religious” fervor of prolonging life at a potential cost of reduced quality of life.
In the upcoming MIXiii-BIOMED 2020 conference we will focus our attention to this very important issue of “Quality of our extended lives – Pros and Cons”.
Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement
Amy Schulman
Managing Partner, Polaris Partners
Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering
Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)
Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center
Maurice R. Ferre, MD
CEO and Chairman of the Board, Insightec
Jeremy Levin MD
CEO and Chairman, Ovid Therapeutics
Eric H. Rubin MD
Senior VP, Global Clinical Oncology, Merck & Co
Aharon Aharon
CEO, Israel Innovation Authority (IIA)
The Israeli Biomed Unicorns
Amir Gross, Ex-CEO, Valtech
Ori Hadomi, Ex-CEO, Mazor Robotics
Prof. Raphael Beyar, MD, PhD, Co-Founder, Corindus
Oded S. Lieberman, PhD, MBA, Ex-CEO, NeuroDerm
Asaf Danziger, CEO, Novocure
Prof. David Sidransky, MD
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund
Barry Greene
President, Alnylam Pharmaceuticals
Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer
Yaron, Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX
Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures
Prof. Varda Shalev, MD, MPA
Director, Institute of Research and Innovation, Maccabitech
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund
Ori Hadomi
VP New Business Development & Partnerships, Medtronic
Anat Naschitz
Managing Director, OrbiMed Advisors
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures
Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma
Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Rosana Kapeller-Libermann, PhD
EIR, Google Ventures
Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics
Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Research
Eric de La Fortelle, PhD
Venture Partner, Seventure
Pierre Belichard
CEO, Enterome
